Sep 21 | Mar 21 | Sep 20 | Mar 20 | Sep 19 | |
---|---|---|---|---|---|
Income Statement | - | ||||
Total Revenue | - | - | - | - | - |
Gross Profit | - | - | - | - | - |
EBIT | - | - | - | - | - |
EBITDA | - | - | - | - | - |
Net Income Common Stockholders | - | - | - | - | - |
Balance Sheet | - | ||||
Cash, Cash Equivalents and Short-Term Investments | $ 1.96M | $ 99.00K | $ 223.00K | $ 66.00K | $ 78.00K |
Total Assets | $ 6.65M | $ 3.97M | $ 3.39M | $ 2.90M | $ 2.88M |
Total Debt | $ ― | $ ― | $ ― | $ ― | $ ― |
Net Debt | $ ― | $ ― | $ ― | $ ― | $ ― |
Total Liabilities | $ 2.72M | $ 1.72M | $ 1.54M | $ 1.64M | $ 1.18M |
Stockholders Equity | $ 1.32M | $ 2.25M | $ 1.85M | $ 1.26M | $ 1.71M |
Cash Flow | - | ||||
Free Cash Flow | - | - | - | - | - |
Operating Cash Flow | - | - | - | - | - |
Investing Cash Flow | - | - | - | - | - |
Financing Cash Flow | - | - | - | - | - |